Sample result
GLP-1, a diabetes hormone
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
- Search
- Protein → Patent proteins · Automatic (Smith-Waterman)
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 5,000 sequences, 3,061 publications, 1,851 families
Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.
Patents
3,061 publications in 1,851 families match these filters.
-
JP 2019511497-A2019-04-25
EXTENDED RELEASE CONJUGATES OF EXENATIDE ANALOGS
PROLYNX LLC,Eric L SCHNEIDER,Brian HEARN,Jeffrey C HENISE,Gary W ASHLEY, Daniel V SANTI
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
EP 3491006-A12019-06-05
PROCESS FOR PREPARATION OF PROTEIN OR PEPTIDE
DR REDDYS LABORATORIES LTD
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3491006-A12019-06-05
- JP 2019528686-A2019-10-17
-
US 10344069-B22019-07-09
Process for the preparation of liraglutide
Auro Peptides Ltd.
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
JP 2019519479-A2019-07-11
Dipeptidyl peptidase-4 inhibitors for use in the topical eye treatment of retinal neurodegenerative diseases, in particular in early stages of diabetic retinopathy and other retinal diseases in which neurodegeneration plays an essential role
Fundacio Hospital Universitari Vall d'Hebron-Institut de Recerca
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2019229225-A12019-12-05
CONJUGATES COMPRISING AN GLP-1/GLUCAGON/GIP TRIPLE RECEPTOR AGONIST, A LINKER AND HYALURONIC ACID
SANOFI SA
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
US 10519211-B22019-12-31
Compounds as peptidic GLP1/glucagon/GIP receptor agonists
SANOFI
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
US 10538567-B22020-01-21
Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonists
SANOFI
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020200044909-A2020-04-29
PHARMACEUTICAL CONSTRUCTS WITH ENHANCED BINDING AFFINITY WITH ALBUMIN
IMMUNWORK INC
Query Match 98.1%Identity 96.8%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200044909-A2020-04-29
- EP 3684414-A12020-07-29
- JP 2021501798-A2021-01-21
- US 10993986-B22021-05-04
-
JP 2020513834-A2020-05-21
EXPRESSION AND LARGE SCALE PRODUCTION OF PEPTIDE
LUPIN LIMITED
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2020188510-A22020-09-24
PROCESS OF PREPARATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS AND THEIR ANALOGS
ENZENE BIOSCIENCES LTD
Query Match 98.1%Identity 96.8%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020188510-A22020-09-24
- KR 1020210141600-A2021-11-23
- JP 2022526115-A2022-05-23
-
US 10851146-B22020-12-01
Method for preparing liraglutide intermediate polypeptide
AMPHASTAR NANJING PHARMACEUTICALS INC.
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210010365-A2021-01-27
FUSION TAG FOR PREPARING PROTEIN OR POLYPEPTIDE
PEPGENE INC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210010366-A2021-01-27
FUSION TAG FOR PREPARING GLUCAGON-LIKE PEPTIDE-1 OR ANALOGUES
PEPGENE INC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210010367-A2021-01-27
FUSION TAG FOR PREPARING HUMAN PARATHYROID HORMONE 1-34
PEPGENE INC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210010368-A2021-01-27
FUSION TAG FOR PREPARING GLUCAGON-LIKE PEPTIDE-2 OR ANALOGUES
PEPGENE INC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2021023892-A12021-02-11
A METHOD FOR MODIFICATION OF PEPTIDES IMMOBILIZED ON A SOLID SUPPORT BY TRACELESS REDUCTIVELY CLEAVABLE LINKER MOLECULES
BELYNTIC GMBH
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2021023892-A12021-02-11
- JP 2022543427-A2022-10-12
-
US 11013738-B22021-05-25
Dipeptidyl peptidase-4 inhibitors for topical eye treatment of retinal neurodegenerative diseases
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON-INSTITUT DE RECERCA
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210063309-A2021-06-01
METHOD FOR PRODUCTION OF HUMAN PARATHYROID HORMONE 1-34 WITH GROES PUSION
PEPGENE INC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210063310-A2021-06-01
METHOD FOR PRODUCTION OF GLUCAGON-LIKE PEPTIDE-2 OR ANALOGUES WITH GROES PUSION
PEPGENE INC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210064144-A2021-06-02
METHOD FOR PRODUCTION OF GLUCAGON-LIKE PEPTIDE-1 OR ANALOGUES WITH GROES PUSION
PEPGENE INC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210071859-A2021-06-16
FUSION TAG FOR PRODUCING PEPTIDE AND PROTEIN
KIM, SUNG GUN
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210071860-A2021-06-16
FUSION TAG FOR PREPARING GLUCAGON-LIKE PEPTIDE-1 OR ANALOGUES
KIM, SUNG GUN
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210071861-A2021-06-16
FUSION TAG FOR PREPARING GLUCAGON-LIKE PEPTIDE-2 OR ANALOGUES
KIM, SUNG GUN
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020210071862-A2021-06-16
FUSION TAG FOR PREPARING OXYNTOMODULIN
PEPGENE INC.
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2021185968-A12021-09-23
FRAGMENTS OF HLYA AND USES THEREOF
NUMAFERM GMBH
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
EP 3894387-A12021-10-20
ACYLATION PROCESS FOR PREPARATION OF N-SUBSTITUTED PEPTIDE
LEVIM BIOTECH LLP
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020220007555-A2022-01-18
FUSION PROTEIN COMPRISING GLUCAGON-LIKE PEPTIDE-1 AND IL-1 RECEPTOR ANTAGONIST AND USE THEREOF
GI Innovation, Inc
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020220008788-A2022-01-21
FUSION PROTEIN COMPRISING GLP-1 AND GLP-2 AND USE THEREOF
GI Innovation, Inc
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020220058631-A2022-05-09
N-TERMINAL EXTENSION SEQUENCE FOR EXPRESSION OF RECOMBINANT THERAPEUTIC PEPTIDES
Biological E Limited
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220058631-A2022-05-09
- JP 2022548598-A2022-11-21
-
JP 2022528057-A2022-06-08
Process for Purifying Liraglutide
Scinopharm Taiwan Ltd
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2022528057-A2022-06-08
- US 11459354-B22022-10-04
-
KR 1020220131221-A2022-09-27
BARCODED XTEN POLYPEPTIDES AND COMPOSITIONS THEREOF, AND METHODS FOR MAKING AND USING THE SAME
Amunix Pharmaceuticals, Inc
Query Match 98.1%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||||| | Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGKG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220131221-A2022-09-27
- JP 2023501478-A2023-01-18
-
US 11518794-B22022-12-06
Synthesis method for liraglutide with low racemate impurity
SHENZHEN JYMED TECHNOLOGY CO., LTD.
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
US 11541123-B22023-01-03
Dual amylin and calcitonin receptor agonists and uses thereof
Eli Lilly and Company
Query Match 98.1%Identity 96.8%Family of 6
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 6
Grouped by the same title and applicant. No priority claim is on record.
- US 11541123-B22023-01-03
- KR 1020230146004-A2023-10-18
- JP 2024500163-A2024-01-04
- JP 2024174929-A2024-12-17
- JP 2026027233-A2026-02-18
- US 12558430-B22026-02-24
-
US 11590206-B22023-02-28
Liquid pharmaceutical composition
SANOFI
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020230047396-A2023-04-07
ANTIVIRAL USE OF LIRAGLUTIDE AND GEFITINIB
DELTA 4 GMBH
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230047396-A2023-04-07
- JP 2023536591-A2023-08-28
-
KR 1020230109107-A2023-07-19
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NUERODEGENERATIVE DISEASE COMPRISING GLUCAGON-LIKE PEPTIDE-1 AND IL-1 RECEPTOR ANTAGONIST
GI Innovation, Inc
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020230144058-A2023-10-13
SUBTILISIN VARIANTS AND THEIR USE
FRESENIUS KABI IPSUM S.R.L
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020230165291-A2023-12-05
CONSTRUCTS AND METHODS FOR INCREASED EXPRESSION OF POLYPEPTIDES
Biological E Limited
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020230165291-A2023-12-05
- JP 2024513203-A2024-03-22
-
US 11845781-B22023-12-19
Fusion protein comprising fibroblast growth factor 19 (FGF 19) and glucagon-like peptide-1
Jiangnan University
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
EP 4345104-A12024-04-03
METHOD FOR PREPARING LIRAGLUTIDE
BACHEM HOLDING AG
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
EP 4384530-A12024-06-19
PURIFICATION OF LIRAGLUTIDE
BIOCON LTD
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
KR 1020240126450-A2024-08-20
IONIC LIQUID COMPOSITIONS
I2O THERAPEUTICS, INC
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020240126450-A2024-08-20
- EP 4429704-A12024-09-18
-
US 12115217-B22024-10-15
Self-replicating RNA and uses thereof
Trustees of Boston University
Query Match 98.1%Identity 96.8%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- US 12115217-B22024-10-15
- KR 1020250109206-A2025-07-16
- JP 2025539792-A2025-12-09
-
EP 4444352-A12024-10-16
COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION
IMAGINE PHARMA LLC
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 51 to 81. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 51 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 8130 of 31 identical, no gaps.
-
EP 4464329-A12024-11-20
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES, CONTAINING GLUCAGON-LIKE PEPTIDE-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST
GI INNOVATION INC
Query Match 98.1%Identity 100.0%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
JP 2024544920-A2024-12-05
IONIC LIQUID COMPOSTIONS
I2O THERAPEUTICS, INC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
WO 2025014754-A12025-01-16
COMPOSITIONS CONTAINING, AND COMBINATION THERAPIES USING BEMPEDOIC ACID AND A GLP-1 RECEPTOR AGONIST
ESPERION THERAPEUTICS INC
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
US 12233110-B22025-02-25
Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereof
i20 Therapeutics, Inc.
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
US 12233111-B22025-02-25
Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereof
i2O Therapeutics, Inc.
Query Match 98.1%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
-
US 12233112-B22025-02-25
Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereof
i2O Therapeutics, Inc.
Query Match 98.1%Identity 96.8%Family of 2
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
Query 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31 ||||||||||||||||||||||||||| ||| Hit 1 HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG 3130 of 31 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 12233112-B22025-02-25
- US 12337029-B22025-06-24